Scheen has received lecturer/scientific advisor/clinical investigator fees from AstraZeneca, Boehringer Ingelheim, Eli Lilly, Merck Sharp & Dohme, and NovoNordisk, and has worked as a clinical investigator in the EMPA-REG OUTCOME, CANVAS-R, DECLARE-TIMI 58, LEADER and HARMONY Outcomes cardiovascular outcome trials
Consult the pharmaceutical packaging for each GLP-1 medication for a complete list of drug side effects, warnings, safety information, interactions and additional information
If you take Ozempic, Wegovy, Mounjaro, Zepbound, semaglutide, tirzepatide, or another GLP-1 medication, you may wonder whether you need to stop it before cosmetic surgery
While lifestyle changes like healthy eating and exercise remain essential, many patients are turning to medical treatments for added support
Any information you provide through use of the Services may be stored and processed, transferred between and accessed from the United States and other countries which may not guarantee the same level of protection of personal information as the one in which you reside
